Does the media refer more to DGX or CCRN?

In the previous week, Quest Diagnostics had 13 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for Quest Diagnostics and 1 mentions for Cross Country Healthcare. Quest Diagnostics' average media sentiment score of 0.99 beat Cross Country Healthcare's score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer CCRN or LH?

In the previous week, Labcorp had 7 more articles in the media than Cross Country Healthcare. MarketBeat recorded 8 mentions for Labcorp and 1 mentions for Cross Country Healthcare. Labcorp's average media sentiment score of 1.29 beat Cross Country Healthcare's score of 0.00 indicating that Labcorp is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Labcorp 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CCRN or DVA?

In the previous week, DaVita had 9 more articles in the media than Cross Country Healthcare. MarketBeat recorded 10 mentions for DaVita and 1 mentions for Cross Country Healthcare. DaVita's average media sentiment score of 0.73 beat Cross Country Healthcare's score of 0.00 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DaVita 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CCRN or CHE?

In the previous week, Chemed had 2 more articles in the media than Cross Country Healthcare. MarketBeat recorded 3 mentions for Chemed and 1 mentions for Cross Country Healthcare. Chemed's average media sentiment score of 1.21 beat Cross Country Healthcare's score of 0.00 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Chemed 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cross Country Healthcare (CCRN) Competitors

$13.17 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$13.17 0.00 (0.00%)

As of 06/18/2026 05:27 PM Eastern

Compare

CCRN vs. AMN, DGX, LH, DVA, and CHE

Should you buy Cross Country Healthcare stock or one of its competitors? MarketBeat compares Cross Country Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cross Country Healthcare include AMN Healthcare Services (AMN), Quest Diagnostics (DGX), Labcorp (LH), DaVita (DVA), and Chemed (CHE). These companies are all part of the "health care services" industry.

How does Cross Country Healthcare compare to AMN Healthcare Services?

Cross Country Healthcare (NASDAQ:CCRN) and AMN Healthcare Services (NYSE:AMN) are both small-cap health care services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cross Country Healthcare currently has a consensus price target of $12.05, indicating a potential downside of 8.50%. AMN Healthcare Services has a consensus price target of $25.29, indicating a potential downside of 18.47%. Given Cross Country Healthcare's higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

AMN Healthcare Services has a net margin of -0.95% compared to Cross Country Healthcare's net margin of -9.84%. AMN Healthcare Services' return on equity of 18.01% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Cross Country Healthcare has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Cross Country Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A

In the previous week, AMN Healthcare Services had 12 more articles in the media than Cross Country Healthcare. MarketBeat recorded 13 mentions for AMN Healthcare Services and 1 mentions for Cross Country Healthcare. AMN Healthcare Services' average media sentiment score of 0.42 beat Cross Country Healthcare's score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AMN Healthcare Services	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

Summary

AMN Healthcare Services beats Cross Country Healthcare on 11 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Cross Country Healthcare (NASDAQ:CCRN) are both health care services companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Quest Diagnostics has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	1.95	$992M	$9.05	21.52
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

In the previous week, Quest Diagnostics had 13 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for Quest Diagnostics and 1 mentions for Cross Country Healthcare. Quest Diagnostics' average media sentiment score of 0.99 beat Cross Country Healthcare's score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quest Diagnostics has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market.

Quest Diagnostics presently has a consensus target price of $216.58, indicating a potential upside of 11.19%. Cross Country Healthcare has a consensus target price of $12.05, indicating a potential downside of 8.50%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe Quest Diagnostics is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 0.9% of Quest Diagnostics shares are held by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Quest Diagnostics has a net margin of 9.07% compared to Cross Country Healthcare's net margin of -9.84%. Quest Diagnostics' return on equity of 15.60% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.07%	15.60%	7.06%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Summary

Quest Diagnostics beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Labcorp?

Cross Country Healthcare (NASDAQ:CCRN) and Labcorp (NYSE:LH) are both health care services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Labcorp has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
Labcorp	$13.95B	1.50	$876.50M	$11.29	22.67

Labcorp has a net margin of 6.66% compared to Cross Country Healthcare's net margin of -9.84%. Labcorp's return on equity of 16.29% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Labcorp	6.66%	16.29%	7.62%

Cross Country Healthcare currently has a consensus target price of $12.05, suggesting a potential downside of 8.50%. Labcorp has a consensus target price of $308.00, suggesting a potential upside of 20.33%. Given Labcorp's stronger consensus rating and higher possible upside, analysts clearly believe Labcorp is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Labcorp	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.8% of Labcorp shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Labcorp had 7 more articles in the media than Cross Country Healthcare. MarketBeat recorded 8 mentions for Labcorp and 1 mentions for Cross Country Healthcare. Labcorp's average media sentiment score of 1.29 beat Cross Country Healthcare's score of 0.00 indicating that Labcorp is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Labcorp	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cross Country Healthcare has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, Labcorp has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

Summary

Labcorp beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to DaVita?

Cross Country Healthcare (NASDAQ:CCRN) and DaVita (NYSE:DVA) are both health care services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

DaVita has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
DaVita	$13.64B	0.98	$746.80M	$10.78	19.26

Cross Country Healthcare has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, DaVita has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market.

Cross Country Healthcare currently has a consensus price target of $12.05, suggesting a potential downside of 8.50%. DaVita has a consensus price target of $199.17, suggesting a potential downside of 4.08%. Given DaVita's stronger consensus rating and higher probable upside, analysts clearly believe DaVita is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
DaVita	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.38

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by insiders. Comparatively, 1.5% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

DaVita has a net margin of 5.65% compared to Cross Country Healthcare's net margin of -9.84%. Cross Country Healthcare's return on equity of -0.74% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
DaVita	5.65%	-270.37%	4.87%

In the previous week, DaVita had 9 more articles in the media than Cross Country Healthcare. MarketBeat recorded 10 mentions for DaVita and 1 mentions for Cross Country Healthcare. DaVita's average media sentiment score of 0.73 beat Cross Country Healthcare's score of 0.00 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DaVita	5 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats Cross Country Healthcare on 14 of the 17 factors compared between the two stocks.

How does Cross Country Healthcare compare to Chemed?

Cross Country Healthcare (NASDAQ:CCRN) and Chemed (NYSE:CHE) are both health care services companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Cross Country Healthcare currently has a consensus target price of $12.05, suggesting a potential downside of 8.50%. Chemed has a consensus target price of $501.50, suggesting a potential upside of 14.80%. Given Chemed's stronger consensus rating and higher probable upside, analysts plainly believe Chemed is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Chemed has a net margin of 10.23% compared to Cross Country Healthcare's net margin of -9.84%. Chemed's return on equity of 27.18% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Chemed	10.23%	27.18%	17.38%

In the previous week, Chemed had 2 more articles in the media than Cross Country Healthcare. MarketBeat recorded 3 mentions for Chemed and 1 mentions for Cross Country Healthcare. Chemed's average media sentiment score of 1.21 beat Cross Country Healthcare's score of 0.00 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemed	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
Chemed	$2.53B	2.29	$265.24M	$18.35	23.81

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cross Country Healthcare has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Chemed has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

Summary

Chemed beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

Get Cross Country Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCRN vs. The Competition

Export

Metric	Cross Country Healthcare	Staffing Industry	Business Sector	NASDAQ Exchange
Market Cap	$425.48M	$1.15B	$6.75B	$12.60B
Dividend Yield	N/A	3.97%	3.19%	5.81%
P/E Ratio	-4.32	13.61	28.87	24.42
Price / Sales	0.40	2.98	377.97	111.09
Price / Cash	24.96	11.68	22.95	37.84
Price / Book	1.34	3.27	5.75	6.60
Net Income	-$94.85M	$7.19M	$205.44M	$337.10M
7 Day Performance	N/A	-0.45%	6.14%	0.83%
1 Month Performance	0.92%	16.08%	7.37%	2.25%
1 Year Performance	-6.13%	-12.80%	35.64%	36.14%

Cross Country Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCRN Cross Country Healthcare	1.8963 of 5 stars	$13.17 flat	$12.05 -8.5%	-6.1%	$425.48M	$1.05B	N/A	6,784	News Coverage High Trading Volume
AMN AMN Healthcare Services	1.7178 of 5 stars	$30.93 -2.4%	$25.29 -18.3%	+41.4%	$1.23B	$2.73B	N/A	2,664	News Coverage Analyst Upgrade Insider Trade Analyst Revision
DGX Quest Diagnostics	4.8042 of 5 stars	$197.07 -1.6%	$216.58 +9.9%	+8.6%	$22.17B	$11.04B	21.78	57,000	News Coverage Analyst Upgrade
LH Labcorp	4.2768 of 5 stars	$261.67 -1.3%	$308.00 +17.7%	-2.3%	$21.74B	$13.95B	23.18	71,000	Positive News
DVA DaVita	4.3083 of 5 stars	$191.84 -0.2%	$199.17 +3.8%	+51.9%	$12.34B	$13.64B	17.80	78,000	Insider Trade Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCRN) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AMN, DGX, LH, DVA, and CHE

How does Cross Country Healthcare compare to AMN Healthcare Services?

Summary

How does Cross Country Healthcare compare to Quest Diagnostics?

Summary

How does Cross Country Healthcare compare to Labcorp?

Summary

How does Cross Country Healthcare compare to DaVita?

Summary

How does Cross Country Healthcare compare to Chemed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AMN, DGX, LH, DVA, and CHE

How does Cross Country Healthcare compare to AMN Healthcare Services?

Do institutionals and insiders have more ownership in CCRN or AMN?

Do analysts prefer CCRN or AMN?

Is CCRN or AMN more profitable?

Which has better earnings & valuation, CCRN or AMN?

Does the media refer more to CCRN or AMN?

Which has more volatility & risk, CCRN or AMN?

Summary

How does Cross Country Healthcare compare to Quest Diagnostics?

Which has higher valuation and earnings, DGX or CCRN?

Does the media refer more to DGX or CCRN?

Which has more volatility & risk, DGX or CCRN?

Do analysts recommend DGX or CCRN?

Do institutionals & insiders have more ownership in DGX or CCRN?

Is DGX or CCRN more profitable?

Summary

How does Cross Country Healthcare compare to Labcorp?

Which has stronger valuation & earnings, CCRN or LH?

Is CCRN or LH more profitable?

Do analysts rate CCRN or LH?

Do institutionals and insiders believe in CCRN or LH?

Does the media prefer CCRN or LH?

Which has more risk & volatility, CCRN or LH?

Summary

How does Cross Country Healthcare compare to DaVita?

Which has stronger earnings & valuation, CCRN or DVA?

Which has more risk & volatility, CCRN or DVA?

Do analysts recommend CCRN or DVA?

Do institutionals & insiders hold more shares of CCRN or DVA?

Is CCRN or DVA more profitable?

Does the media refer more to CCRN or DVA?

Summary

How does Cross Country Healthcare compare to Chemed?

Do analysts recommend CCRN or CHE?

Is CCRN or CHE more profitable?

Does the media prefer CCRN or CHE?

Which has better valuation & earnings, CCRN or CHE?

Do insiders & institutionals hold more shares of CCRN or CHE?

Which has more volatility & risk, CCRN or CHE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools